Livagen Peptide (20mg)

Buy Livagen Peptide (20mg) Online

Livagen is a synthetic tetrapeptide composed of Lys-Glu-Asp-Ala (KEDA). It belongs to the peptide-bioregulator family developed in Russian research and has been studied primarily in cellular, animal, and biochemical models.

Product Information

Livagen has been investigated for tissue-specific biological effects, including research involving liver and cellular-aging pathways. Experimental work has also examined its interaction with enzymes involved in the endogenous opioid system.

How It Works

The precise biological mechanism of Livagen has not been fully established. Experimental research suggests that it can influence cellular processes and inhibit certain enkephalin-degrading enzymes, providing a possible link to neuroendocrine and tissue-regulatory pathways.

POTENTIAL BENEFITS

1. Cellular Aging Research

Livagen is part of the broader bioregulator research program examining whether short peptides can influence age-associated cellular changes. Research has focused on tissue-specific biological regulation rather than a single conventional receptor target.

2. Liver Research

Early experimental work investigated Livagen in relation to liver-tissue biology. These studies form part of the rationale for continued research into tissue-specific peptide regulation.

3. Enzyme Activity Research

In vitro research found that Livagen inhibited enkephalin-degrading enzymes in human serum. This provides a measurable biochemical effect that can be studied independently of broader anti-aging claims.

4. Peptide-Bioregulator Research

Livagen is useful as a research model for investigating how very short endogenous-like peptides may influence cellular function. Its evidence base remains substantially smaller than that of established pharmaceutical compounds.

Dosage

There is no standardized clinical dosage for Livagen. Published work is largely experimental, and reported research protocols are not sufficient to establish a validated human dosing regimen.

Side Effects

Controlled modern human safety data for Livagen are limited. Its long-term tolerability and complete pharmacological profile therefore remain insufficiently characterized.

References

1. Khavinson VK, et al. *Tissue-specific effects of peptides.*
2. Effect of new peptide bioregulators Livagen and Epitalon on enkephalin-degrading enzymes in human serum.
3. Peptides and ageing — review of peptide bioregulator research.

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.